H.C.
OHR Pharmaceutical Inc (NASDAQ:OHRP) is confronting the aftermath of Fovista’s pivotal two Phase 3 failures that both missed the primary endpoint in neovascular …
In a research report released this morning, Canaccord analyst Corey Davis reiterated a Buy rating on shares of Synergy Pharmaceuticals Inc (NASDAQ:SGYP) with a …
Canaccord analyst Corey Davis weighed in today with a favorable report on shares of Pacira Pharmaceuticals Inc (NASDAQ:PCRX), reiterating a Buy rating and a price …
Canaccord’s healthcare analyst Corey Davis weighed in with a few insights on Pacira Pharmaceuticals Inc (NASDAQ:PCRX), after the company announced that it is suing the …
Canaccord analyst Corey Davis came out today with a favorable report on Synergy Pharmaceuticals Inc (NASDAQ:SGYP), after the company announced positive top-line results from the second of …
Inotek Pharmaceuticals Corp (NASDAQ:ITEK) shares are up 10.67% to $17.
Canaccord Genuity analyst Corey Davis initiated coverage on shares of Lipocine Inc (NASDAQ:LPCN) with a Buy rating and a price target of $15.00, which implies an upside …
Canaccord Genuity analyst Corey Davis came out with a favorable report on Aerie Pharmaceuticals Inc (NASDAQ:AERI) after the FDA allowed ROCKET 2’s primary endpoint …
